Publications by authors named "Kate Talks"

Claim this Profile
L
Laboratory investigation and clinical management of acquired coagulation factor inhibitors: A joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline.
Charles Percy, Anne Riddell, Kate Talks, Julia Anderson, Shawn Cotton

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' Organisation.
Caroline Wall, Hua Xiang, Ben Palmer, Pratima Chowdary, Peter W Collins, Kate Talks

Res Pract Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal.
Manuela Albisetti, Jesús Ardila, Jan Astermark, Jan Blatny, Manuel Carcao, Kate Talks

Haemophilia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease.
Mark W Skinner, Manuela Albisetti, Jesús Ardila, Jan Astermark, Jan Blatny, Kate Talks

Haemophilia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
Nichola Cooper, Marie Scully, Charles Percy, Phillip L R Nicolson, Gillian Lowe, Kate Talks

Br J Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel.
Mike Laffan, Paul McLaughlin, Jayashree Motwani, Jayanthi Alamelu, Steve Austin, Kate Talks

Haemophilia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-rich plasma and macular hole surgery: A clue to their mode of action and the influence of anti-platelet agents.
Francesco Maria D'Alterio, Mariantonia Ferrara, Alan Bagnall, Kate L Talks, Roxane J Hillier

Eur J Ophthalmol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
Caroline Wall, Hua Xiang, Ben Palmer, Elizabeth Chalmers, Pratima Chowdary, Kate Talks

Haemophilia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.
Pratima Chowdary, Susan Shapiro, Mike Makris, Gillian Evans, Sara Boyce, Kate Talks

N Engl J Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.
Daniel P Hart, Jayanthi Alamelu, Neha Bhatnagar, Tina Biss, Peter W Collins, Kate Talks

Haemophilia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
Charlotte A Bradbury, Julie Pell, Quentin Hill, Catherine Bagot, Nichola Cooper, Kate Talks

N Engl J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B.
Rachel Rayment, Elizabeth Chalmers, Katherine Forsyth, Richard Gooding, Anne M Kelly, Kate Talks

Br J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists.
Jecko Thachil, Catherine Bagot, Charlotte Bradbury, Nichola Cooper, Will Lester, Kate Talks

Br J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.
Emmanouela Kampouraki, Peter J Avery, Hilary Wynne, Tina Biss, John Hanley, Kate Talks

Br J Haematol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoiesis Shows Closer Correlation with Calculated Free Testosterone in Men than Total Testosterone.
David R Woods, Neil E Hill, R Dermot G Neely, Kate L Talks, Alison Heggie

J Appl Lab Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.
Peter W Collins, Elizabeth Chalmers, Daniel Hart, Ian Jennings, Ri Liesner, Kate Talks

Br J Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Peter W Collins, Elizabeth Chalmers, Daniel P Hart, Ri Liesner, Savita Rangarajan, Kate Talks

Br J Haematol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.
Tadeusz Robak, Jerzy Windyga, Jacek Trelinski, Mario von Depka Prondzinski, Aristoteles Giagounidis, Kate Talks

Blood· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
Michael I Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, Constantinos Simopoulos, Helen Turley, Kate Talks

Int J Radiat Oncol Biol Phys· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Ipatia A Doussis-Anagnostopoulou, Kate L Talks, Helen Turley, Paul Debnam, Daphne C Tan

J Pathol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer.
Russell D Leek, Kate L Talks, Francesco Pezzella, Helen Turley, Leticia Campo

Cancer Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis